Pneumoniae Epidemiology Study in China
NCT00471770 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2008-03-13
Summary
To determine the proportion of hospitalized pneumonia cases in children aged 60 months or less associated with vaccine-preventable Streptococcus pneumoniae serotypes (4, 6B, 9V, 14, 18C, 19F, 23F).
Conditions
- Pneumococcal Disease
Sponsors & Collaborators
-
Wyeth is now a wholly owned subsidiary of Pfizer
lead INDUSTRY
Principal Investigators
-
Medical Monitor · Wyeth is now a wholly owned subsidiary of Pfizer
Eligibility
- Max Age
- 60 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-02-28
- Primary Completion
- 2008-02-29
- Completion
- 2008-02-29
Countries
- China
Study Locations
More Related Trials
-
A Study to Learn About How Safe and Effective is 20vPnC and 13vPnC Vaccines in Chinese Adults
NCT07019909 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Subjects
NCT01531322 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Volunteers Aged Above 2 Months
NCT04108845 ·Status: UNKNOWN ·Phase: PHASE1
-
Study Evaluating 7-Valent Pneumococcal Conjugate Vaccine in Healthy Infants
NCT00488826 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and Elderly
NCT02451969 ·Status: COMPLETED ·Phase: PHASE3
-
PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae
NCT02133469 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine
NCT06617715 ·Status: RECRUITING ·Phase: PHASE3
-
Pneumonia Research and Vaccine Impact League
NCT03900520 ·Status: COMPLETED
-
A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria
NCT01193582 ·Status: COMPLETED ·Phase: PHASE4
-
Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above
NCT04100772 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China
NCT01692886 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers
NCT04357522 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Immunity to Serotype 19A Streptococcus Pneumoniae in Children Vaccinated With PCV10
NCT04912297 ·Status: COMPLETED
-
A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People
NCT06044077 ·Status: RECRUITING ·Phase: PHASE3
-
Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide Vaccine
NCT05477693 ·Status: COMPLETED ·Phase: PHASE4
-
Streptococcus Pneumonia: Effects of PCV13 on Pneumococcal Carriage
NCT01109108 ·Status: COMPLETED
-
Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine
NCT05092386 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target Population
NCT07071701 ·Status: COMPLETED
-
Paediatric Pneumococcal Pneumonia in Malaysia Prior to and During Pneumococcal Conjugate Vaccine (PCV) Implementation
NCT04923035 ·Status: ACTIVE_NOT_RECRUITING
-
Safety and Immunogenicity of a Newly 23-valent Pneumococcal Polysaccharide Vaccine in Chinese Adults and Children
NCT02285036 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months,7 Months-5 Years
NCT06210737 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of PCV Schedules in a Naive Population in Vietnam
NCT02961231 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Antibody Response of Healthy Chinese Children Who Have Been Vaccinated Previously With 4-doses of Prevenar (a Pneumococcal Vaccine) as Babies and Toddlers
NCT01298544 ·Status: COMPLETED ·Phase: PHASE4
-
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants
NCT04382326 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Evaluate the Safety and Immunogenicity of PPV23 Vaccine Revaccinated in 60-70 Years Old
NCT04700618 ·Status: COMPLETED ·Phase: PHASE4